Haiwang Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Haiwang Capital is a platform for managing funds of Pudong Science and Technology Innovation Group.
Investor Profile
Haiwang Capital has backed more than 5 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Pharmaceutical, Biopharma.
Stage Focus
- Series A (40%)
- Series Unknown (40%)
- Series C (20%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Biopharma
- Life Science
- Hardware
- Optical Communication
- Product Research
- Advanced Materials
- Manufacturing
- Semiconductor
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
